医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

JETRO Osaka (Japan External Trade Organization): Making an Innovation Movement From Osaka

2022年01月28日 AM11:00
このエントリーをはてなブックマークに追加


 

OSAKA, Japan

The Kansai region, which includes unique cities of Osaka, Kobe and Kyoto, is a massive market with a population of 24.65 million people and a GDP of approximately 100.05 trillion yen. It equals the metropolitan area centered on Tokyo as a site for business and plays the central role in the economy of Western Japan.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220124005319/en/

Succeed Together in Japan and Beyond (Graphic: Business Wire)

Succeed Together in Japan and Beyond (Graphic: Business Wire)

In this region, particularly on the Osaka Gulf Coast, there is a cluster of companies and research institutes related to the environmental and new energy industries. Also, throughout Osaka City, bio-related pharmaceutical companies and food manufacturers gather as well as the chemical and medical equipment companies.

[Source] JETRO Investing in Japan “Osaka City”
https://www.jetro.go.jp/en/invest/region/data/osaka-city.html
O-BIC “Industry of Osaka”
https://o-bic.net/e/attractive/

As the host city of the next World Expo in 2025, Osaka has been a hot spot for startups attracting various companies and people from all over the world.

Boosting up innovation movement, Global Innovation Conference Hack Osaka Executive Committee* will host Startup Business Meetings from February 8th (Tue) to 9th (Wed), co-organized by Osaka Prefecture, as one of the programs of Annual Global Innovation Conference, Hack Osaka 2022.

* The committee composes of Osaka City, Urban Innovation Institute, JETRO Osaka, and Osaka Business Development Agency.

In 2022, with the themes of “Next-Generation Air Mobility” and “Infrastructure”, a talk session between companies engaging in eVTOL development, reverse pitch by corporations in Kansai region, and global pitch contest Hack Award 2022 are waiting to be streamed.

Hack Osaka 2022
Date: Thursday, Feb. 10th, 2022 1 p.m. –7 p.m. (JST)
Registration: https://www.innovation-osaka.jp/hackosaka/en/index.php

Startup Business Meetings 2022
Date: Tuesday, Feb. 8th to Wednesday, Feb. 9th, 2022 9 a.m. – 8 p.m. (JST)
Information: https://www.innovation-osaka.jp/hackosaka/en/business-meeting.php

[List of Startups]

UrbanChain Group Limited

Hong Kong

(Smart parking)

Autofleet

Israel

(Fleet management)

HeyCharge GmbH

Germany

(EV charge in in-door environment)

H3 Dynamics

Singapore

(Hydrogen propulsion drone × AI)

MobyFly

Switzerland

(Zero-emission hydrofoil)

FLYING WHALES

France

(Air freight solution with loads of 60t)

Sharper Shape Inc.

USA

(Digital twin for utility infrastructure)

INFINITE FOUNDRY

Brazil

(3D Digital twin for industries)

Asilla, Inc.

Japan

(AI security system)

NanoLock security

Israel

(Zero-trust security for IoT devices)

BYSTAMP

France

(Digital stamp)

Falkonry Inc.

USA

(Fact-based insights for manufacturing with AI)

Innoviz Technologies

Israel

(3D LiDAR)

Materna IPS GmbH

Germany

(Biometrics × passenger processing)

Verily Vision

Thailand

(Logistics automation at ports, warehouses, factories)

Details of Startups: https://www.innovation-osaka.jp/hackosaka/assets/doc/2022-participants/en/all-business2022-en.pdf

View source version on businesswire.com: https://www.businesswire.com/news/home/20220124005319/en/

CONTACT

[Inquiries]

Global Innovation Conference Hack Osaka Executive Committee (JETRO Osaka)

Aki Hirahata

TEL: +81 6-4705-8603 (Mon – Fri 9:30 a.m. – 5:30 p.m. Closed during national holidays)

E-mail: osd@jetro.or.jp

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Xlear与Dr. Ferrer BioPharma合作,向用户提供更佳鼻腔卫生体验
  • ネブラスカ大学医療センターとアナンダ・サイエンティフィックが心的外傷後ストレス障害(PTSD)の治療を探究する臨床試験のINDをFDAが承認と発表
  • APCER Life Sciences Expands Integrated Pharmacovigilance Services with Oracle Argus Cloud Service
  • Propanc Biopharma Undertaking PRP Manufacturing & Development for Human Use
  • Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period